Ping An Insurance Group's technology arm, Ping An Technology, has completed a prospective multi-centre clinical trial for the world's first intelligent optical coherence tomography (OCT) retinal disease screening system. This development comes amidst Ping An's constant advancements in leveraging AI and its strong medical repository to establish a healthcare ecosystem.